PENGARUH PROFITABILITAS, LEVERAGE DAN UKURAN PERUSAHAAN TERHADAP NILAI PERUSAHAAN PADA PERUSAHAAN FARMASI YANG TERDAFTAR DI BURSA EFEK INDONESIA TAHUN 2018-2022

Abstract

This research aimed to examine the effect of profitability, leverage, and firm size on the firm value of pharmaceutical companies listed on the Indonesia Stock Exchange (IDX). Return On Asset measured profitability, Devt to Equity Ratio measured leverage, and Firm Size measured firm size. The research was quantitative. Moreover, the population was 10 pharmaceutical companies listed on the Indonesia Stock Exchange (IDX). The data collection technique used purposive sampling, in which the sample was based on the criteria given. In line with that, there were 7 companies as the sample. Furthermore, the data were taken for 5 years (2018-2022). The data analysis technique used multiple linear regression with SPSS 29. The result showed that probability (Return On Asset) positively and significantly affected firm value. However, leverage (Debt to Equity Ratio) had a negative and significant effect on firm value. On the other hand, firm size (Firm Size) had a positive but insignificant effect on firm value.